Natural killer cells and engagers: Powerful weapons against cancer
Immunological Reviews · 2024-11 · 328 (1) · 412-421
DOI: 10.1111/imr.13384 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunological Reviews, online erschienen am 24.08.2024. Verfasst von Cristina Bottino und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Experimental Medicine (DIMES), University of Genova, Genoa, Italy. Hauptthemen laut MEDLINE: Immunity, Innate, Immunotherapy, Killer Cells, Natural, Neoplasms. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Agence Nationale de la Recherche, PIONEER Project, Ministero della Salute, 5x1000 grants, European Research Council (ERC), TREATLIVMETS.
Abstract (Originalsprache)
Natural killer (NK) cells are innate immune effectors whose functions rely on receptors binding cytokines, recognizing self‐molecules, or detecting danger signals expressed by virus‐infected or tumor cells. The potent cytotoxic potential makes NK cells promising candidates for cancer immunotherapy. To enhance their activity strategies include cytokine administration, blocking of immune checkpoints, and designing of antibody‐based NK cell engagers (NKCEs). NKCEs represent a cutting‐edge approach to cancer therapy: they strengthen the NK‐to‐target cell interactions and optimize tumor killing, possibly overcoming the immunosuppressive tumor microenvironment. NK cells belong to the innate lymphoid cells (ILCs) and are categorized into different subsets also including cells with a memory‐like phenotype: this complexity needs to be explored in the context of cancer immunotherapy, particularly when designing NKCEs. Two strategies to enhance NK cell activity in cancer patients can be adopted: activating patients' own NK cells versus the adoptive transfer of ex vivo activated NK cells. Furthermore, the capability of NKCEs to activate γδ T cells could have a significant synergistic effect in immunotherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Experimental Medicine (DIMES), University of Genova, Genoa, Italy.
- Laboratory of Clinical and Experimental Immunology, IRCCS Istituto Giannina Gaslini, Genoa, Italy.
- Innate Pharma Research Laboratories, Innate Pharma, Marseille, France.
- Centre National de la Recherche Scientifique, INSERM, Centre d'Immunologie de Marseille-Luminy, Aix Marseille Université, Marseille, France.
- Assistance Publique-Hôpitaux de Marseille, Hôpital de la Timone, Marseille Immunopôle, Marseille, France.
ORCID-Profile: Cristina Bottino
Förderung
- Agence Nationale de la Recherche, PIONEER Project
- Ministero della Salute, 5x1000 grants
- European Research Council (ERC), TREATLIVMETS
- Agence Nationale de la Recherche
- Ministero della Salute
Zitieren
APA
Bottino, C., Picant, V., Vivier, E., & Castriconi, R. (2024). Natural killer cells and engagers: Powerful weapons against cancer. Immunological Reviews, 328(1), 412-421. https://doi.org/10.1111/imr.13384
Vancouver
Bottino C, Picant V, Vivier E, Castriconi R. Natural killer cells and engagers: Powerful weapons against cancer. Immunological Reviews. 2024;328(1):412-421. doi:10.1111/imr.13384
BibTeX
@article{Bottino2024,
author = {Bottino, Cristina and Picant, Valentin and Vivier, Eric and Castriconi, Roberta},
title = {Natural killer cells and engagers: Powerful weapons against cancer},
journal = {Immunological Reviews},
year = {2024},
volume = {328},
number = {1},
pages = {412--421},
doi = {10.1111/imr.13384}
}
EUVIMED